• Blog
  • Cephalosporin Market Report

    Cephalosporin Market Report

    Cephalosporin Market Report
    Report code - SRHL199 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Cephalosporin Market Trends, Forecast & Market Analysis
    See more...

    Impact of COVID-19 on Cephalosporin Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Cephalosporin Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Cephalosporin Market is projected to grow from USD 13.89 billion in 2020 to USD 16.35 billion by 2026 at a CAGR of over 2.8% during the forecast period.

    Figure: Global Cephalosporin Market Size, 2020-2026 (USD Billion)

    Cephalosporin-Market-Forecast

    Want to know the full scope of the report? Register Here

    What is Cephalosporin?

    Cephalosporin is a bactericidal and β-lactam antibiotic mainly derived from the fungus Acremonium that is used to treat bactericidal infections such as skin infections, pneumonia, tonsillitis, strep throat, gonorrhoea, staph infections, and bronchitis among others. It inhibits enzymes in the cell wall of the susceptible bacteria and disrupts the cell synthesis. Cephalosporin is majorly designated for prophylaxis as well as for the treatment of infections caused by bacteria

    Key Players

    Key players operating in the global cephalosporin market are-

    • Aristo Pharmaceuticals Ltd (India),
    • Baxter International (The U.S.),
    • F. Hoffmann-La Roche AG (Switzerland),
    • GlaxoSmithKline PLC (UK),
    • Lupin Pharmaceuticals Inc. (India),
    • Macleods Pharmaceuticals Ltd (India),
    • Mankind Pharma (India),
    • Merck & Co. Inc. (The U.S.),
    • Pfizer Inc. (The U.S.), and
    • Teva Pharmaceutical Industries Ltd. (Israel).

    Market Dynamics

    The growing prevalence of infectious diseases and the increase in funding for the development of antibiotics are some of the key factors bolstering the product demand. Additionally, the surge in R&D activities for the production of combination drugs and the rising demand for antibacterial further augment the market growth. Moreover, the discovery of innovative prospect molecules and the introduction of novel combination therapies to treat antibiotic-resistant infections are likely to provide lucrative opportunities to the industry participants. However, the side effects of cephalosporin are likely to hinder the industry expansion.

    Segment Analysis

    Type Trends

    By type, the cephalosporin market has been segmented into branded and generic.

    • Under these, the generic segment held a considerable market share in 2020 and is likely to register the fastest CAGR during the review period.
    • This is mainly attributed to the easy availability of drugs at a lower cost when compared to branded drugs.
    • Also, the pharmacological effects of generic drugs are almost the same as those of their brand-name equivalents.

    Regional Trends

    By region, the Asia Pacific market witnessed the highest market share in 2020 and is estimated to grow at a substantial CAGR during the assessment period.

    • This is mainly ascribed to the rise in consumption of cephalosporin, upsurge in demand for over-the-counter drugs, easier availability, and increasing bacterial infections in the Asia Pacific.
    • Moreover, growing healthcare expenditure and improving standards of living with large population growth further boosts the regional growth.

    COVID-19 Impact on Global Cephalosporin Market

    The outbreak of the COVID-19 virus has considerably affected the cephalosporin industry. Cephalosporin has not been proven highly effective against viruses. β-lactam antibiotics such as cephalosporin possess a bacteriostatic effect. The bacteriostatic action results in the action of subduing the growth of bacteria. β-lactam antibiotics act by preventing peptidoglycan synthase, which is an enzyme necessary for the growth of bacterial cell walls. However, cephalosporin can help to obstruct SARS-CoV-2 but have a minor impact on the market growth.

    Critical Questions Answered in the Report

    • What are the key trends in the global cephalosporin market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on global cephalosporin market?
    • What are the key strategies adopted by the major vendors to lead in the global cephalosporin market?
    • What is the market share of the top vendors?

    Want to know segmentation details? Register Here

    Target Audience

    The following is a list of the customers that the Cephalosporin market aims to convert the most:

    • Cephalosporin companies
    • Cephalosporin vendors
    • R&D companies
    • Hospitals
    • Drug manufacturing companies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The cephalosporin market is expected to grow at an impressive CAGR of 2.8% in the foreseeable future.

    Aristo Pharmaceuticals Ltd (India), Baxter International (The U.S.), F. Hoffmann-La Roche AG (Switzerland), GlaxoSmithKline PLC (UK), Lupin Pharmaceuticals Inc. (India), Macleods Pharmaceuticals Ltd (India), Mankind Pharma (India), Merck & Co. Inc. (The U.S.), Pfizer Inc. (The U.S.), and Teva Pharmaceutical Industries Ltd. (Israel) are among the key players in the cephalosporin market.

    The cephalosporin market size is expected to reach USD 16.35 billion in the coming years.

    Asia Pacific market witnessed the highest market share in 2020 and is estimated to grow at a substantial CAGR during the assessment period.

    The generic segment is expected to register the fastest CAGR in the cephalosporin market in the coming five years.

    The growing prevalence of infectious diseases and the increase in funding for the development of antibiotics are some of the key factors bolstering the demand for cephalosporin.

    Cephalosporin companies, Cephalosporin vendors, R&D companies, Hospitals, Drug manufacturing companies are the target audience in the cephalosporin market.

    •